NCT06169202 2023-12-13
A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients
China Medical University, China
Unknown
China Medical University, China
Hallym University Medical Center
University Hospital, Caen
University of Pisa
King Faisal Specialist Hospital & Research Center